Close X
Monday, November 11, 2024
ADVT 
Health

'Ebola vaccine showing promising results'

Darpan News Desk IANS, 02 Dec, 2014 12:49 PM
    Two Ebola vaccines undergoing clinical trials have shown promising results and would be deployed in January 2015 to West African countries affected by the epidemic, a scientist from Oxford University said Monday.
     
    Speaking at a conference of African Immunologists in Nairobi, Adrian Hill, director of Oxford University's Jenner Institute, said the two vaccines will re-energise the fight against Ebola, Xinhua reported.
     
    "The two vaccines have demonstrated remarkable efficacy and have no side effects to Ebola patients. We anticipate their deployment will commence in January," Hill told African medical researchers.
     
    The World Health Organisation (WHO) Nov 29 revealed that 6,928 people have died of Ebola in Liberia, Guinea and Sierra Leone.
     
    At the same time, 16,000 people are infected with the Ebola virus and could succumb to death in the absence of proper treatment and care.
     
    Pharmaceutical giants, rich governments, foundations and multilateral agencies have contributed funds to support development of an Ebola vaccine.
     
    Hill said that clinical trials on Ebola vaccine have accelerated thanks to adequate funding and political attention.
     
    "Development of an Ebola vaccine is accelerating faster than anticipated. The vaccine is being tested in Mali where 80 people have received the jab," Hill said, adding that over 200 people have been vaccinated against Ebola globally.
     
    The clinical trials on Ebola vaccine commenced in September and the WHO will approve it once it passes efficacy and safety test.
     
    Hill revealed that pharmaceutical giants, British and American governments have collaborated to develop the Ebola vaccine.
     
    Clinical trials on Ebola vaccine have involved primates since the disease was discovered in 1976 in the Democratic Republic of Congo.
     
    "There was a breakthrough in the clinical trials targeting monkeys and the next phase will focus on the vaccines` efficacy on humans," Hill told scientists.
     
    He emphasised the vaccine will be a game changer in the war against Ebola in West and Central Africa.
     
    "The vaccine will be availed to high risk groups like health workers and people involved in burials," Hill said. 

    MORE Health ARTICLES

    Recreational drug use linked to birth defects

    Recreational drug use linked to birth defects
    Babies born to mothers who used recreational drugs during pregnancy are more likely to have birth defects in the brain, said a study....

    Recreational drug use linked to birth defects

    Insomnia triples risk of motor accident deaths

    Insomnia triples risk of motor accident deaths
    Developing a healthy sleeping habit could be a life saviour as researchers have found that insomnia significantly increases risk of death caused by...

    Insomnia triples risk of motor accident deaths

    Public awareness needed to check breast cancer: Experts

    Public awareness needed to check breast cancer: Experts
    With around 1.5 lakh breast cancer cases being diagnosed every year in India, health experts Saturday called for more public awareness and community...

    Public awareness needed to check breast cancer: Experts

    Drugs to abet cancer cells suicide found

    Drugs to abet cancer cells suicide found
    The combination of two drugs, called TRAIL and a CDK9 inhibitor, forced the cancer cells to self-destruct, the findings showed....

    Drugs to abet cancer cells suicide found

    Young heart can heal itself faster

    Young heart can heal itself faster
    Washington- The heart holds its own pool of immune cells capable of helping it to heal after injury, finds research, adding that the harmful...

    Young heart can heal itself faster

    How genes affect Ebola patients

    How genes affect Ebola patients
    New York- The Ebola virus affects different people differently, say researchers, adding that genetic factors could be behind this mild-to-deadly....

    How genes affect Ebola patients